Co-Diagnostics
CODX
CODX
37 hedge funds and large institutions have $4.29M invested in Co-Diagnostics in 2024 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 8 increasing their positions, 9 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
more funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
22% less capital invested
Capital invested by funds: $5.52M → $4.29M (-$1.23M)
68% less call options, than puts
Call options by funds: $97K | Put options by funds: $299K
Holders
37
Holding in Top 10
–
Calls
$97K
Puts
$299K
Top Buyers
| 1 | +$886K | |
| 2 | +$53.7K | |
| 3 | +$21.3K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$18.2K |
| 5 |
TSS
Two Sigma Securities
New York
|
+$12.3K |
Top Sellers
| 1 | -$14K | |
| 2 | -$13.6K | |
| 3 | -$13.2K | |
| 4 |
Renaissance Technologies
New York
|
-$9.07K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$8.3K |